It is commonly thought that the use of vascular access systems (native arterio-venous fistula or vascular grafts) within the early postoperative period should be avoided. In “Guidelines for vascular access construction and repair for chronic hemodialysis”, the use of native arterio-venous fistula is recommended to begin two weeks postoperatively and that of vascular grafts three to four weeks postoperatively.
In emergencies, if it becomes necessary to start hemodialysis, we have to catheterize the patients. As a result, infection and a decline in the patient's activities of daily living reduce the patient's overall quality of life. Upon reviewing three years of data from 95 patients who received hemodialysis (68 graft cases) between April 2001 and March 2003, we found that the complications that occurred within one month postoperatively were due to exposure of the vascular graft by diastasis (1 case) and thrombosis (5 cases).
The primary patency rates of native arterio-venous fistula at 1, 2, and 3 years were 72.1%, 64.7%, and 60.3%, respectively. The secondary patency rates of native arterio-venous fistula at 1, 2, and 3 years were 72.1%, 64.7%, and 60.3%, respectively. The primary patency rates of vascular grafts at 1, 2, and 3 years were 70.4%, 48.1%, and 44.4%, respectively. The secondary patency rates of vascular grafts at 1, 2, and 3 years were 85.2%, 81.5%, and 74.1% respectively. Based on these findings, we conclude that use of the blood access systems in the early postoperative period reduces the need for hospitalization due to hemodialysis and blood access complications. Thus, this method contributes not only to the patient's quality of life, but also relieves some of the financial burden due to medical expenses.
View full abstract